(Q44967081)

7 December 2017

Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen (English)

1 reference

7 December 2017

Bord S

1

1 reference

7 December 2017

Frith E

2

1 reference

7 December 2017

Ireland DC

3

1 reference

7 December 2017

Scott MA

4

1 reference

7 December 2017

Craig JI

5

1 reference

7 December 2017

Compston JE

6

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

British Journal of Haematology

7 December 2017

1 reference

7 December 2017

126

1 reference

7 December 2017

244-251

1 reference

7 December 2017

2

1 reference

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Mechanisms by which high-dose estrogen therapy produces anabolic skeletal effects in postmenopausal women: role of locally produced growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

The regulation of megakaryocytopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Real-time quantitative RT-PCR after laser-assisted cell picking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

Skeletal effects of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05024.X

10.1111/J.1365-2141.2004.05024.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference